{"title": "Quinazolone RVX-208 effect on liver carcinoma cell line", "description": "Analysis of HepG2 liver carcinoma cells treated with the quinazolone RVX-208 or the triazolothienodiazepine JQ1, a BET bromodomain (BD) inhibitor. BET protein dysfunction is linked to cancer. Results provide insight into the difference in affinity of RVX-208 for the 1st and 2nd BDs in BET proteins.", "type": "Expression profiling by array", "pubmed_id": "24248379", "platform": "GPL6244", "platform_organism": "Homo sapiens", "platform_technology_type": "in situ oligonucleotide", "feature_count": "33297", "sample_organism": "Homo sapiens", "sample_type": "RNA", "channel_count": "1", "sample_count": "8", "value_type": "transformed count", "reference_series": "GSE51143", "order": "none", "update_date": "Nov 20 2014", "subsets": [{"dataset_id": "GDS5340", "description": "control", "sample_id": ["GSM1239644", "GSM1239645", "GSM1239646"], "type": "agent", "id": "GDS5340_1"}, {"dataset_id": "GDS5340", "description": "JQ1", "sample_id": ["GSM1239647", "GSM1239648"], "type": "agent", "id": "GDS5340_2"}, {"dataset_id": "GDS5340", "description": "RVX-208", "sample_id": ["GSM1239649", "GSM1239650", "GSM1239651"], "type": "agent", "id": "GDS5340_3"}], "taxid": "9606", "genes": 26803, "aggregation_function": "mean", "name": "GDS5340", "version": 1.0, "instances": "8", "variables": 26805, "target": "", "gene_as_attribute_name": true, "gene_id_attribute": "Entrez ID", "url": "http://file.biolab.si/geo/GDS5340.tab", "compression": "gz"}